LIPIDEON BIOTECHNOLOGY AG has a total of 17 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Canada and Australia. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ST DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S P A, INVASC THERAPEUTICS INC and ANANTHAN SUBRAMANIAM.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 3 | |
#3 | Australia | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Sugars | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Hauser Helmut | 12 |
#2 | Carreira Erick | 12 |
#3 | Werder Moritz | 11 |
#4 | Kvaerno Lisbet | 8 |
#5 | Ritter Tobias | 8 |
#6 | Li Dong-Bo | 3 |
#7 | Fessard Thomas | 3 |
#8 | Wolfrum Susanne | 3 |
#9 | Barbaras Damien | 3 |
#10 | Moritz Carreira Erick Hauser H | 1 |
Publication | Filing date | Title |
---|---|---|
EP2403848A1 | Pharmaceutical hypocholesterolemic compositions | |
EP1958941A1 | Oxazolidinones and their use as hypocholesterolemic agents | |
EP1522541A1 | Novel hypocholesterolemic compounds | |
EP1216040A1 | Agents for reducing cholesterol-uptake and lipid-uptake |